wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35943654-0583B10F-8E5D-4BB0-BD04-DA8C83DCCDB5
Q35943654-0583B10F-8E5D-4BB0-BD04-DA8C83DCCDB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35943654-0583B10F-8E5D-4BB0-BD04-DA8C83DCCDB5
Dose-dense temozolomide: is it still promising?
P2860
Q35943654-0583B10F-8E5D-4BB0-BD04-DA8C83DCCDB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35943654-0583B10F-8E5D-4BB0-BD04-DA8C83DCCDB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6935614744c02a772ddac1075655bab8a95ae278
P2860
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas.